hypertriglyceridemia
Conditions
Interventions
Exposure group:None.
Sponsors
Shengjing Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Age =18 years old, gender is not limited; 2. Patient TG> 2.3mmol/L; 3. Patients with 2g/d or 4g/d continuous treatment of Omega-3 fatty acids for 12 weeks (± 2 weeks); 4. Patients with blood lipid examination records of pre -medication and 12 weeks (± 2 weeks);
Exclusion criteria
Exclusion criteria: 1. Women during pregnancy and lactation; 2. Allergies for drug activity ingredients, soybeans, peanuts or other auxiliary materials; 3. Researchers think it is inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TG decrease percentage after treating 12W (± 2W); | — |
Secondary
| Measure | Time frame |
|---|---|
| TG drop percentage after treatment of 4W (± 1W);Treatment of 12W (± 2W) other blood lipid indicators decreased percentage (NHDL-C, TC, VLDL-C, lipoprotein A, lipoprotein B, lipoprotein (A), etc.);Treatment of 12W (± 2W) blood pressure, BMI, waist circumference changes;Evaluation of special benefits for special groups (elderly patients, CKD patients, fatty liver patients and other diseases);Comparison of different doses of curative effect;Analysis of multiple factors that affect the efficacy;Analysis of safety results (liver and kidney function, bleeding, atrial fibrillation, gastrointestinal reaction, etc.);Analysis of the new cardiovascular incident (MACE incident); | — |
Countries
China
Contacts
Public ContactDifei Wang
Shengjing Hospital of China Medical University
Outcome results
None listed